Lucid Diagnostics INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
PAVmed Inc. filed an Amendment No. 6 to its Schedule 13D, detailing updated beneficial ownership in Lucid Diagnostics Inc. and new agreements solidifying its influence as the parent company.
NASDAQ
PAVmed Inc. has increased its beneficial ownership in Lucid Diagnostics Inc. to 28.3% through recent stock awards and voting agreements, solidifying its influence as the parent company.